DCGI issues directive to states, UTs after MP Coldrif case
In a letter dated October 7, the Drugs Controller General of India (DCGI) Dr Rajeev Singh Raghuvanshi emphasised...
DCGI reduces blood bank licensing time to 4 months
The Drugs Controller General of India (DCGI) has reduced the time required for blood bank licensing from a year...
‘11 countries recognise Indian pharmacopoeia as their standard’
Drugs Controller General of India (DCGI) Dr Rajeev Raghuvanshi, has said that 11 countries in the world have...
DCGI constantly monitoring quality of medicines and taking action
As per senior official sources, the DCGI is actively taking action against manufacturing companies producing...
Drug regulator suspends product PresVu over unauthorised promotio
The Drugs Controller General of India (DCGI) on Wednesday suspended the product PresVu produced by Entod...
DCGI bans charges, except supply, processing costs on blood units
The Drugs Controller General of India (DCGI) has waived all charges except processing costs on blood units.
Mandaviya directs regulator to act against spurious drugs maker
Licenses of 18 Pharma companies cancelled
The Government of India has cancelled the licenses of 18 pharma companies for manufacturing spurious medicines...
FICCI writes to Health Ministry on e-pharmacy companies
The Union Ministry of Health is mulling shutting down digital pharmacies due to some concerns like misuse of...
Rajeev Singh Raghuvanshi is new Drugs Controller General of India
The Union Public Service Commission (UPSC) has recommended the name of Dr Rajeev Singh Raghuvanshi as the new...
DCGI recommends Covovax as heterologous booster dose
The Central drug regulatory authority Drugs Controller General of India (DCGI) has recommended market...
DCGI approves '5-arms intranasal hetrologous booster dose'...
Copyright © aninews.in | All Rights Reserved.